David Patience - 01 Jul 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Reporting relationship: Chief Financial Officer
Issuer ticker: TLSI
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jul 2026, 16:01:13 UTC
Prior SEC filing: 18 May 2026
Source filing: View source filing
Reporting owner signature: /s/ David Patience

Key filing fact

David Patience filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 06 Jul 2026.

Key facts

This page summarizes David Patience's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Jul 2026, 16:01.

Change

Previous filing in this sequence was filed on 18 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001970009 Primary reporting owner

Patience David

Relationship: Chief Financial Officer
Address: 6272 W. 91ST AVENUE, WESTMINSTER
Signature: /s/ David Patience
Signature date: 06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLSI transaction

Common Stock

Tax liability

Transaction value
Shares: -14,650
Change %: -5.3%
Price: $4.46^*
Shares after: 261,107
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units previously granted.